MAD2L2 and head and neck squamous cell carcinoma: More recent re-analysis of TCGA dataset showed that up to 13% of HPV-negative sporadic HNSCC cases harbored deletions in FANCV/MAD2L2, FANCR/RAD51, FANCU/XRCC2, as well as ALDH2, a known FA disease modifier.